Artificial intelligence and cheminformatics tools: a contribution to the drug development and chemical science.

Journal: Journal of biomolecular structure & dynamics
Published Date:

Abstract

In the ever-evolving field of drug discovery, the integration of Artificial Intelligence (AI) and Machine Learning (ML) with cheminformatics has proven to be a powerful combination. Cheminformatics, which combines the principles of computer science and chemistry, is used to extract chemical information and search compound databases, while the application of AI and ML allows for the identification of potential hit compounds, optimization of synthesis routes, and prediction of drug efficacy and toxicity. This collaborative approach has led to the discovery, preclinical evaluations and approval of over 70 drugs in recent years. To aid researchers in the pursuit of new drugs, this article presents a comprehensive list of databases, datasets, predictive and generative models, scoring functions and web platforms that have been launched between 2021 and 2022. These resources provide a wealth of information and tools for computer-assisted drug development, and are a valuable asset for those working in the field of cheminformatics. Overall, the integration of AI, ML and cheminformatics has greatly advanced the drug discovery process and continues to hold great potential for the future. As new resources and technologies become available, we can expect to see even more groundbreaking discoveries and advancements in these fields.Communicated by Ramaswamy H. Sarma.

Authors

  • Ifra Saifi
    Chaudhary Charan Singh University, Meerut, Uttar Pradesh, India.
  • Basharat Ahmad Bhat
    Department of Bioresources, School of Biological Sciences, University of Kashmir, Srinagar, J&K, India.
  • Syed Suhail Hamdani
    Department of Bioresources, School of Biological Sciences, University of Kashmir, Srinagar, J&K, India.
  • Umar Yousuf Bhat
    Department of Zoology, School of Biological Sciences, University of Kashmir, Srinagar, J&K, India.
  • Carlos Alberto Lobato-Tapia
    Department de Ciencias Químico-Biológicas, Universidad de las Américas Puebla. San Andrés Cholula, México.
  • Mushtaq Ahmad Mir
    Department of Clinical Laboratory Sciences, College of Applied Medical Science, King Khalid University, KSA, Saudi Arabia.
  • Tanvir Ul Hasan Dar
    Department of Biotechnology, School of Biosciences and Biotechnology, BGSB University, Rajouri, India.
  • Showkat Ahmad Ganie
    Department of Clinical Biochemistry, School of Biological Sciences, University of Kashmir, Srinagar, J&K, India.